Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,665 Cr₹1,817 Cr₹1,669 Cr₹1,541 Cr₹1,242 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,665 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,665 Cr
Mar2024₹1,817 Cr
Mar2023₹1,669 Cr
Mar2022₹1,541 Cr
Mar2021₹1,242 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2025 ₹1,665 Cr
-8.38
Mar2024 ₹1,817 Cr
8.91
Mar2023 ₹1,669 Cr
8.30
Mar2022 ₹1,541 Cr
24.10
Mar2021 ₹1,242 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,855.2 Cr -2.3% -6.7% -9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-2.3%

-6.7%

-9.9%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses